109 completed. 109 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 109 | Completed 109 |
Follow Hypercholesterolemia: new trials by email Literature Review of Hypercholesterolemia trials Research Report on Hypercholesterolemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol Rosuvastatin + Ezetimibe, Bempedoic Acid + Ezetimibe, Rosuvastatin + Ezetimibe + Bempedoic Acid - Type 2 Diabetes Mellitus, Hypercholesterolemia / Elevated LDL Cholesterol | Phase 4 | Completed | Bahria University | 126 | 2026-01-01 | 2026-10-20 |
| A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease. Inclisiran sodium, BPA - Hypercholesterolemia | Phase 4 | Completed | Novartis Pharmaceuticals | 402 | 2024-06-21 | 2026-07-29 |
| Study of Efficacy, Safety, Tolerability and Quality of Life of Inclisiran (KJX839) vs Placebo, on Top of Ongoing Individually Optimized Lipid-lowering Therapy, in Participants With Hypercholesterolemia Inclisiran Sodium, Placebo - Hypercholesterolemia | Phase 4 | Completed | Novartis Pharmaceuticals | 1770 | 2022-04-08 | 2026-04-14 |
| Lipid Management in Renal Transplant Recipients Using Evolocumab. Evolocumab - Hyperlipidemias | Phase 4 | Completed | Brigham and Women's Hospital | 81 | 2021-02-17 | 2026-04-16 |
| Effect of Pitavastatin on Bone Pitavastatin - Osteoporosis, Osteopenia, Hypercholesterolemia | Phase 4 | Completed | Seoul National University Bundang Hospital | 70 | 2019-04-08 | 2024-04-11 |
| Safety and Tolerability of Repatha® (Evolocumab) in Indian Participants With Homozygous Familial Hypercholesterolemia evolocumab - Homozygous Familial Hypercholesterolemia HoFH | Phase 4 | Completed | Amgen | 30 | 2018-08-04 | 2024-05-29 |
| Rosuvastatin/Ezetimibe vs Rosuvastatin in Korean Patients With Type 2 Diabetes Mellitus and Hypercholesterolemia Rosuvamibe® Tab, Monorova® Tab - Type 2 Diabetes Mellitus, Hypercholesterolemia | Phase 4 | Completed | Yuhan Corporation | 140 | 2018-02-23 | 2019-07-23 |
| Impact of Statin Therapy on Adaptations to Aerobic Exercise Lipitor 20Mg Tablet, Lipitor 80Mg Tablet, Placebo - Cardiovascular Diseases | Phase 4 | Completed | University of Kansas Medical Center | 52 | 2018-02-01 | 2025-04-15 |
| Clinical Trial to to Compare of the Efficacy and Safety of Lipilou® 20 mg and Lipilou® 10 mg Lipilou®(generic atorvastatin drug) 20 mg, Lipilou®(generic atorvastatin drug) 10 mg - Hypercholesterolemia | Phase 4 | Completed | Chong Kun Dang Pharmaceutical | 250 | 2017-10-11 | 2020-08-12 |
| A Study to Compare Rosuvastatin/Ezetimibe and Rosuvastatin in Patients With Diabetes Mellitus and Hypercholesterolemia Rosuvastatin+Ezetimibe, Rosuvastatin - Diabetes Mellitus and Hypercholesterolemia | Phase 4 | Completed | Yuhan Corporation | 85 | 2017-08-10 | 2019-09-23 |
| Lipid-lowering Therapy Individualization Atorvastatin - Hypercholesterolemia | Phase 4 | Completed | Université Catholique de Louvain | 75 | 2017-08-08 | 2019-09-03 |
| Evaluation of the Effect of a Shiitake Extract on Lipid Profile in Subjects With Moderate Hyperlipidemia Experimental product, Placebo product - Hypercholesterolemia, Hyperlipidemias | Phase 4 | Completed | Instituto de Investigación Hospital Universitario La Paz | 57 | 2017-05-08 | 2022-01-13 |
| NUtraceutical TReatment for hYpercholesterolemia in HIV-infected Patients Nutraceutical combination (NC), No nutraceutical combination (noNC) - Hypercholesterolemia, Inflammation | Phase 4 | Completed | University Of Perugia | 26 | 2017-01-15 | 2018-03-23 |
| Alirocumab in Patients With Acute Myocardial Infarction alirocumab, placebo - Myocardial Infarction, Hypercholesterolemia | Phase 4 | Completed | Virginia Commonwealth University | 20 | 2017-01-01 | 2019-09-06 |
| Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia Alirocumab SAR236553, Atorvastatin, Rosuvastatin - Hypercholesterolemia, Acute Coronary Syndrome | Phase 4 | Completed | Sanofi | 206 | 2016-11-15 | 2019-09-09 |
| Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo Praluent (Alirocumab), Placebo - Hypercholesterolemia | Phase 4 | Completed | Regeneron Pharmaceuticals | 2176 | 2016-11-02 | 2021-05-07 |
| Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2) Dapagliflozin, Rosuvastatin - Diabetes Mellitus, Type 2, Hypercholesterolemia | Phase 4 | Completed | Amsterdam UMC, location VUmc | 12 | 2016-05-01 | 2020-08-04 |
| Effect of Amlodipine on the Lipid Profile of Newly Diagnosed Hypertensive Patients Amlodipine - Hypercholesterolemia, Hypertension | Phase 4 | Completed | Ayub Teaching Hospital | 80 | 2016-03-01 | 2022-07-20 |
| Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe Rosuvastatin and Ezetimibe morning or evening administration - Hypercholesterolemia | Phase 4 | Completed | Collegium Medicum w Bydgoszczy | 83 | 2016-03-01 | 2021-02-02 |
| Clinical Trial to Evaluate Efficacy and Safety of ROVASRO 10mg Versus CRESTOR 10mg in Hypercholesterolemic Patients CRESTOR, reference formulation of rosuvastatin, ROVASRO, generic formulation of rosuvastatin - Hypercholesterolemia, Dyslipidemias | Phase 4 | Completed | Yonsei University | 126 | 2015-10-23 | 2019-05-14 |
Showing 20 of 109. Sign in to see all of them.
Dyslipidemias (11) · Cardiovascular Diseases (9) · Atherosclerosis (8) · Coronary Artery Disease (7) · Hyperlipidemias (7) · Coronary Disease (6) · Diabetes Mellitus, Type 2 (5) · Hypertension (5) · Insulin Resistance (5) · Hyperlipoproteinemia Type II (3) · Hypertriglyceridemia (3) · Acute Coronary Syndrome (2) · Angina Pectoris (2) · Diabetes Mellitus (2)
Nutritional and Metabolic Diseases (109) · Metabolic Diseases (108) · Lipid Metabolism Disorders (107) · Hyperlipidemias (102) · Dyslipidemias (98) · Vascular Diseases (30) · Cardiovascular Diseases (25) · Arterial Occlusive Diseases (17) · Arteriosclerosis (17) · Myocardial Ischemia (17) · Heart Diseases (16) · Glucose Metabolism Disorders (14) · Coronary Disease (7) · Endocrine System Diseases (7) · Hyperinsulinism (7)
Atorvastatin (29) · Ezetimibe (25) · Simvastatin (18) · Rosuvastatin Calcium (13) · Ezetimibe, Simvastatin Drug Combination (9) · pitavastatin (7) · Hydroxymethylglutaryl-CoA Reductase Inhibitors (5) · Pravastatin (5) · Colesevelam Hydrochloride (4) · Niacin (4) · Amlodipine (3) · alirocumab (3) · Fenofibrate (2) · Fluvastatin (2) · Omacor (2)
Organon and Co (16) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (8) · Daiichi Sankyo (6) · Gachon University Gil Medical Center (5) · Seoul National University Hospital (3) · Yonsei University (3) · AstraZeneca (2) · JW Pharmaceutical (2) · Kumamoto University (2) · Novartis Pharmaceuticals (2) · UCSF Benioff Children's Hospital Oakland (2) · University Of Perugia (2) · University of Kansas Medical Center (2) · Yuhan Corporation (2) · Aalborg University Hospital (1)
United States (25) · South Korea (18) · Japan (9) · France (4) · Spain (4) · Canada (3) · Czechia (3) · Germany (3) · Israel (3) · Norway (3) · Poland (3) · Russia (3) · Taiwan (3) · Austria (2) · Belgium (2)
Ronald M Krauss, M.D. (2) · Alex Laursen, D.M., DMSc (1) · Anh Le, PhD (1) · Anil K Chandraker, MD (1) · Ann-Brit E Hansen, M.D. (1) · Antonio Abbate, MD, PhD (1) · Chang Beom Lee (1) · Ching Jung Hsieh (1) · Christie M. Ballantyne, MD (1)
PMID 10593347, PMID 11781675, PMID 16404415, PMID 16749654, PMID 16893434, PMID 16923260, PMID 17407633, PMID 17578790, PMID 17668878, PMID 18332269, PMID 18545068, PMID 18559695, PMID 18762410, PMID 19167589, PMID 19286582, PMID 19608026, PMID 19879596, PMID 19939653, PMID 20067513, PMID 20298928, PMID 20339536, PMID 20413733, PMID 20467151, PMID 20617456, PMID 20663203, PMID 20684825, PMID 21122660, PMID 21227624, PMID 21271793, PMID 21297494, PMID 21306285, PMID 21699369, PMID 22115011, PMID 22291820, PMID 22621316, PMID 22808006, PMID 22831708, PMID 22913893, PMID 22972364, PMID 23274145, PMID 23289728, PMID 23464930, PMID 23623012, PMID 23863812, PMID 24075764, PMID 24267254, PMID 24339703, PMID 24521776, PMID 25879228, PMID 25929253
2004 (1), 2016 (1), R01AR071263 (1), R01HL075824 (1)